HomeInsightsStock Comparison

Everest Organics Ltd vs Oxygenta Pharmaceutical Ltd Stock Comparison

Everest Organics Ltd vs Oxygenta Pharmaceutical Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Everest Organics Ltd is ₹ 330 as of 16 Jul 15:30.
  • The P/E Ratio of Everest Organics Ltd changed from 7 on March 2020 to 675.3 on March 2024 . This represents a CAGR of 149.39% over 5 yearsThe P/E Ratio of Oxygenta Pharmaceutical Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Everest Organics Ltd changed from ₹ 76 crore on March 2020 to ₹ 91.84 crore on March 2024 . This represents a CAGR of 3.86% over 5 yearsThe Market Cap of Oxygenta Pharmaceutical Ltd changed from ₹ 34.15 crore on March 2022 to ₹ 97.07 crore on March 2024 . This represents a CAGR of 41.65% over 3 years.
  • The revenue of Everest Organics Ltd for the Mar '25 is ₹ 41.15 crore as compare to the Dec '24 revenue of ₹ 42.06 crore. This represent the decline of -2.16% The revenue of Oxygenta Pharmaceutical Ltd for the Mar '25 is ₹ 49.52 crore as compare to the Dec '24 revenue of ₹ 33.69 crore. This represent the growth of 46.99%.
  • The ebitda of Everest Organics Ltd for the Mar '25 is ₹ 3.65 crore as compare to the Dec '24 ebitda of ₹ 4.02 crore. This represent the decline of -9.2% The ebitda of Oxygenta Pharmaceutical Ltd for the Mar '25 is ₹ -1.9 crore as compare to the Dec '24 ebitda of ₹ -3.87 crore. This represent the decline of -50.9%.
  • The net profit of Everest Organics Ltd changed from ₹ 0.04 crore to ₹ 2.91 crore over 8 quarters. This represents a CAGR of 752.94% The net profit of Oxygenta Pharmaceutical Ltd changed from ₹ -4.56 crore to ₹ -2.15 crore over 8 quarters. This represents a CAGR of -31.33% .
  • The Dividend Payout of Everest Organics Ltd changed from 7.34 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Oxygenta Pharmaceutical Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Everest Organics Ltd

  • Everest Organics Limited was incorporated at Hyderabad in February, 1993.
  • It was promoted by S K Srihari Raju and S K. Chittiramabhadra Raju.
  • The Company is engaged in manufacturing of Active Pharmaceutical Ingredients and their intermediaries.
  • The Company commenced its commercial operations in the year 1993.
  • It set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations.

About Oxygenta Pharmaceutical Ltd

  • Oxygenta Pharmaceutical Limited (Formerly known S S Organics Ltd) was incorporated as Private Limited Company in year 1990 and converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.
  • Later, the Company changed its name from S.S. Organics Ltd. to Oxygenta Pharmaceutical Limited in 2021-22. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs.
  • The Company is doing contract manufacturing work for APL and also having its own production.
  • The Company is engaged in manufacture of bulk drugs.
  • It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs.

Everest Organics Ltd News Hub

News

Everest Organics schedules board meeting

Everest Organics will hold a meeting of the Board of Directors of the Company on 27 May 20...

Read more

22 May 2025 19:46

News

Everest Organics hits the roof after securing KDMF nod for Rabeprazole Sodium API

The Rabeprazole Sodium API is primarily used to treat conditions related to excessive stom...

Read more

18 Feb 2025 15:45

News

Everest Organics to conduct board meeting

Everest Organics will hold a meeting of the Board of Directors of the Company on 11 Februa...

Read more

06 Feb 2025 13:41

News

Everest Organics to hold board meeting

Everest Organics will hold a meeting of the Board of Directors of the Company on 13 Januar...

Read more

09 Jan 2025 09:31

News

Everest Organics EGM scheduled

Everest Organics announced that an Extra Ordinary General Meeting (EGM) of the Company wil...

Read more

17 Dec 2024 17:42

News

Everest Organics spurts as board to mull fund raising on Dec 10

According to the regulatory filing, the board will discuss and approve a proposal to raise...

Read more

09 Dec 2024 11:23

Oxygenta Pharmaceutical Ltd News Hub

News

Oxygenta Pharmaceutical to discuss results

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 30...

Read more

27 May 2025 16:54

News

Oxygenta Pharmaceutical to convene board meeting

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14...

Read more

11 Feb 2025 14:01

News

Oxygenta Pharmaceutical announces board meeting date

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14...

Read more

10 Feb 2025 10:03

News

Oxygenta Pharmaceutical announces board meeting date

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14...

Read more

11 Nov 2024 11:06

News

Oxygenta Pharmaceutical schedules AGM

Oxygenta Pharmaceutical announced that the 31th Annual General Meeting (AGM) of the compan...

Read more

18 Sep 2024 10:58

News

Oxygenta Pharmaceutical to discuss results

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14...

Read more

12 Aug 2024 14:50

SWOT Analysis Of Oxygenta Pharmaceutical Ltd

Strength

0

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Everest Organics Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Oxygenta Pharmaceutical Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Everest Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Everest Organics Ltd and Oxygenta Pharmaceutical Ltd

Which company has a larger market capitalization, Everest Organics Ltd or Oxygenta Pharmaceutical Ltd?

Market cap of Everest Organics Ltd is 320 Cr while Market cap of Oxygenta Pharmaceutical Ltd is 414 Cr

What are the key factors driving the stock performance of Everest Organics Ltd and Oxygenta Pharmaceutical Ltd?

The stock performance of Everest Organics Ltd and Oxygenta Pharmaceutical Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Everest Organics Ltd and Oxygenta Pharmaceutical Ltd?

As of July 16, 2025, the Everest Organics Ltd stock price is INR ₹330.0. On the other hand, Oxygenta Pharmaceutical Ltd stock price is INR ₹112.0.

How do dividend payouts of Everest Organics Ltd and Oxygenta Pharmaceutical Ltd compare?

To compare the dividend payouts of Everest Organics Ltd and Oxygenta Pharmaceutical Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions